Small team, specialized R2 Diagnostics is a small biotech manufacturer with a focused product line in hemostasis reagents and coagulation controls, suggesting a need for scalable supplier partnerships, contract manufacturing capabilities, and reliable logistics to support growth.

Regulatory pedigree The company is FDA 21 CFR 820 compliant and ISO 13485 certified, indicating a strong emphasis on quality systems and regulatory readiness—a selling point for customers requiring compliant supply of coagulation reagents and clinical kits.

Diverse reagent portfolio Product offerings include low ISI thromboplastin, heparin and lupus sensitive APTT, Protein S kits, kaolin KCT for automated coagulometers, LA screening reagents, thrombin time and fibrinogen kits, plus collaboration with Enzyme Research Laboratories; opportunities exist to cross-sell related products and expand reagent lines.

Technology and channels Presence of modern tech stack and online channels (WordPress, Shopify/WooCommerce, open graph) suggests potential for digital marketing and e-commerce expansion, direct-to-lab sales, and easier discovery by clinical labs seeking coagulation solutions.

Growth signals Revenue range ($1M–$10M) and a news history including a flagship product launch indicate growth activity; target labs and smaller clinics in need of compliant, reliable coagulation reagents and ready-to-use controls could be strategic prospects for expansion and long-term partnerships.